Compare Danaher Corporation (DHR) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Freeport-McMoRan Inc — how do they compare? Danaher Corporation trades at $203.46 (market cap $144.67B), while Freeport-McMoRan Inc trades at $66.7 (market cap $96.91B). The key difference: Danaher Corporation is the larger of the two by market cap, and Freeport-McMoRan Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| DHR | FCX | |
|---|---|---|
Market Cap | $144.67B | $96.91B |
Sector | Health | Basic Materials |
52-Week High | $242.05 | $71.73 |
52-Week Low | $161.91 | $35.34 |
Enterprise Value | $166.88B | $103.19B |
Dividend Yield | 0.78% | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $204.02, down 1.65% on the day, with a bullish technical outlook supported by moving averages and a recent history of earnings beats. The company maintains strong profitability margins and positive cash flow, though revenue growth has moderated. Recent news highlights product launches and a pending acquisition of Masimo, approved by shareholders in May 2026.
The stock presents a balanced outlook with solid fundamentals and analyst support, but faces risks from integration challenges and macroeconomic pressures. Upside is supported by a consensus price target of $202.33, while valuation multiples remain elevated relative to historical norms.
FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.
The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
